These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 722494)

  • 1. GLC--mass spectrometry of several important anticancer drugs II: doxorubicin and daunorubicin aglycone analogs.
    Chan KK; Watson E
    J Pharm Sci; 1978 Dec; 67(12):1748-52. PubMed ID: 722494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GLC--mass spectrometry of several important anticancer drugs I: pertrimethylsilylation and O-methoxime formation.
    Watson E; Chan KK
    J Pharm Sci; 1978 Sep; 67(9):1243-6. PubMed ID: 690828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adriamycin and daunorubicin disposition in the rabbit.
    Bachur NR; Hildebrand RC; Jaenke RS
    J Pharmacol Exp Ther; 1974 Nov; 191(2):331-40. PubMed ID: 4417723
    [No Abstract]   [Full Text] [Related]  

  • 4. Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.
    Maniez-Devos DM; Baurain R; Lesne M; Trouet A
    J Pharmacol; 1986; 17(1):1-13. PubMed ID: 3713196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversed-phase liquid chromatography of adriamycin and daunorubicin and their hydroxyl metabolites adriamycinol and daunorubicinol.
    Eksborg S
    J Chromatogr; 1978 Feb; 149():225-32. PubMed ID: 649731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disposition and metabolism of N,N-dimethyldaunorubicin and N,N-dimethyladriamycin in rabbits and mice.
    Egorin MJ; Clawson RE; Ross LA; Chou FT; Andrews PA; Bachur NR
    Drug Metab Dispos; 1980; 8(5):353-62. PubMed ID: 6107235
    [No Abstract]   [Full Text] [Related]  

  • 7. A fluorometric determination of adriamycin and its metabolites in biological tissues.
    Chan KK; Harris PA
    Res Commun Chem Pathol Pharmacol; 1973 Sep; 6(2):447-63. PubMed ID: 4750095
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro formation of a toxic aglycone metabolite of 4-demethoxydaunorubicin in conditions that parallel the stomach.
    Cummings J; Milroy R
    Anticancer Res; 1986; 6(5):1177-9. PubMed ID: 3467647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rapid chromatographic procedure for the determination of adriamycin, daunomycin and their 13-OH metabolites adriamycinol and daunomycinol.
    Erb N; Erttmann R; Landbeck G
    Cancer Chemother Pharmacol; 1986; 17(1):53-5. PubMed ID: 3698178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of new derivatives of daunorubicin and adriamycin with DNA.
    Arlandini E; Vigevani A; Arcamone F
    Farmaco Sci; 1977 May; 32(5):315-23. PubMed ID: 862886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypothesis concerning possible new derivatives of daunorubicin and adriamycin with enhanced DNA-binding properties.
    Neidle S
    Cancer Treat Rep; 1977 Aug; 61(5):928-9. PubMed ID: 890699
    [No Abstract]   [Full Text] [Related]  

  • 12. Synthesis and radioiodination of some daunorubicin and doxorubicin derivatives.
    Ghirmai S; Mume E; Tolmachev V; Sjöberg S
    Carbohydr Res; 2005 Jan; 340(1):15-24. PubMed ID: 15620662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular pharmacology of amino acid derivatives of daunorubicin and doxorubicin in suspension of renal proximal tubules.
    Hjelle JT; Baurain R; Masquelier M; Trouet A
    J Pharmacol Exp Ther; 1984 May; 229(2):372-80. PubMed ID: 6585548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daunorubicin metabolites in human urine.
    Takanashi S; Bachur NR
    J Pharmacol Exp Ther; 1975 Oct; 195(1):41-9. PubMed ID: 1181403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Self-association of doxorubicin and related compounds in aqueous solution.
    Menozzi M; Valentini L; Vannini E; Arcamone F
    J Pharm Sci; 1984 Jun; 73(6):766-70. PubMed ID: 6588195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA.
    Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M
    Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence assay of tissue distribution of 4-demethoxydaunorubicin and 4-demethoxydoxorubicin in mice bearing solid tumors.
    Formelli F; Casazza AM; Di Marco A; Mariani A; Pollini C
    Cancer Chemother Pharmacol; 1979; 3(4):261-9. PubMed ID: 294954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast atom bombardment mass spectrometric analysis of anthracyclines and anthracyclinones.
    Dass C; Seshadri R; Israel M; Desiderio DM
    Biomed Environ Mass Spectrom; 1988 Jul; 17(1):37-45. PubMed ID: 3203147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of the anthracycline antibiotic daunorubicin to daunorubicinol and deoxydaunorubicinol aglycone in hepatocytes isolated from the rat and the rabbit.
    Gewirtz DA; Yanovich S
    Biochem Pharmacol; 1986 Nov; 35(22):4059-64. PubMed ID: 3778526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ["Chimeric" antibiotics, daunorubicin and its analogs N-acylated with bruneomycin (Streptonigrin)].
    Tolstikov VV; Kozlova NV; Iartseva IV; Preobrazhenskaia MN
    Bioorg Khim; 1989 Feb; 15(2):277-80. PubMed ID: 2500939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.